Initial functional status predicts infections during steroid therapy for renal diseases

Clinical Nephrology

Volumn 63, Issue 2, 2005, Pages 68-73

  Sakuma, Y ^a   Katoh, T ^a   Owada, K ^a   Suzuki, H ^a   Sakurai, K ^a   Eiro, M ^a   Asahi, K ^a   Watanabe, T ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Infection markers; Karnofsky's performance score; Steroid therapy

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; STEROID;

AGE; ARTICLE; CORRELATION ANALYSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INFECTION; KIDNEY DISEASE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; PATIENT CARE; PREDICTION; PROGNOSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; STEROID THERAPY;

EID: 14544277066     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP63068     Document Type: Article

References (23)

1. Al-Kassab AS, Vijyayakumar E 1995 Profile of serum cholinesterase in systemic sepsis syndrome (septic shock) in intensive care unit patients. Eur J Clin Chem Clin Biochem 33: 11-14
2. Bargman JM 1999 Management of minimal lesion glomerulonephritis. Evidence-based recommendations. Kidney Int Suppl 70: 3-16
3. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, Morrin PA, Lavoie S 1995 A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 47: 1130-1135
4. Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K 1999 Is there a rationing chronic dialysis? A hospital-based cohort study on factors affecting survival and mobility. BMJ 318: 217-223
5. Delgado-Rodriguez M, Medina-Cuadros M, Gomez-Ortega A, Martinez-Gallego G, Mariscal-Ortiz M, Martinez-Gonzalez MA, Sillero-Arenas M 2002 Cholesterol and albumin levels as predicators of cross infection, death, and hospital stay. Arch Surg 137: 805-812
6. Fauci AS, Dale DC, Balow JE 1976 Glucocorticosteroid therapy: mechanism of action and clinical considerations. Ann Intern Med 84: 304-315
7. Funabiki K, Tomino Y, Shirato I, Yoshida M, Koide H 1992 Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid. Jpn J Nephrol 34: 997-1001
8. Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K, Taguma Y 2001 Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 38: 736-743
9. Howard A, Austin, James E. Balow 1999 Natural History and Treatment of Lupus Nephritis. Semin Nephrol 19: 2-11
10. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M 1993 Infection in systemic lupus erythematosus. J Med Assoc Thai 76: 542-548
11. Jindal KK 1999 Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations. Kidney Int Suppl 70: 33-40
12. Karnofsky DA, Abelman WH, Graver LF, Burchenal JH 1948 The use of nitrogen mustard in palliative treatment of carcinoma. Cancer 1: 634-656
13. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S 1996 Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron 72: 237-242
14. Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ 1995 The efficacy of cyclosporine A in adult nephritic syndrome with minimal-change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea. Clin Nephrol 43: 375-381
15. Martin F, Lauwerys B, Lefebvre C, Devogelaer JP, Houssiau FA 1997 Side effect of intravenous cyclophosphamide pulse therapy. Lupus 6: 254-257
16. Nordoy I, Muller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS 1999 Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients. J Infect Dis 180: 195-198
17. Ooi BS, Cohen DJ 1995 Host immune deficiency in immune complex nephritis. J Am Soc Nephrol 6: 1342-1346
18. Ponticelli C, Passerini P 1991 Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. Clin Nephrol 35 (Suppl 1): 16-21
19. Sakai H, Abe K, Kobayashi Y, Koyama A, Shigematsu H, Harada T, Yoshikawa N, Arakawa M, Itoh H, Osawa G 1995 Clinical guideline of IgA nephropathy. Jpn J Nephrol 37: 417-421
20. Sakai H, Kurokawa K, Koyama A, Arimura Y, Kida H, Shigematsu H, Suzuki S, Nihei H, Makino H, Ueda N, Kawamura T, Gejyo F, Saito T, Harada T, Hiki Y, Yoshida M 2002 Guidelines for the management of rapidly progressive glomerulonephritis. Jpn J Nephrol 44: 55-82
21. Segal BH, Sneller MC 1997 Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 23: 219-237
22. Stuck AE, Minder CE, Frey FJ 1989 Risk of infectious complications in patients in taking glucocorticosteroids. Rev Infect Dis 11: 959-963
23. Yuhara T, Takemura H, Akama T, Suzuki H, Yamane K, Kashiwagi H 1996 Predicting infection in hospitalized patients with systemic lupus crythematosus. Intern Med 35: 629-634